Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.0 - $0.38 $0 - $56,801
-149,477 Closed
0 $0
Q4 2022

Aug 11, 2023

BUY
$0.74 - $1.83 $5,948 - $14,711
8,039 Added 5.68%
149,477 $133,000
Q4 2022

Feb 13, 2023

BUY
$0.74 - $1.83 $5,948 - $14,711
8,039 Added 5.68%
149,477 $133,000
Q3 2022

Aug 11, 2023

SELL
$1.51 - $2.88 $4,720 - $9,002
-3,126 Reduced 2.16%
141,438 $222,000
Q3 2022

Nov 03, 2022

SELL
$1.51 - $2.88 $4,720 - $9,002
-3,126 Reduced 2.16%
141,438 $222,000
Q2 2022

Aug 11, 2023

BUY
$1.24 - $2.33 $35,843 - $67,350
28,906 Added 24.99%
144,564 $290,000
Q2 2022

Aug 15, 2022

BUY
$1.24 - $2.33 $35,843 - $67,350
28,906 Added 24.99%
144,564 $291,000
Q1 2022

Aug 11, 2023

BUY
$2.0 - $4.9 $231,316 - $566,724
115,658 New
115,658 $269,000
Q1 2022

May 20, 2022

SELL
$2.0 - $4.9 $55,188 - $135,210
-27,594 Reduced 19.26%
115,658 $269,000
Q4 2021

Feb 16, 2022

BUY
$4.65 - $7.23 $24,924 - $38,752
5,360 Added 3.89%
143,252 $666,000
Q3 2021

Nov 12, 2021

SELL
$7.41 - $10.99 $73,047 - $108,339
-9,858 Reduced 6.67%
137,892 $1.05 Million
Q2 2021

Aug 12, 2021

BUY
$6.35 - $10.0 $78,079 - $122,960
12,296 Added 9.08%
147,750 $1.43 Million
Q1 2021

May 03, 2021

SELL
$7.03 - $16.51 $59,396 - $139,492
-8,449 Reduced 5.87%
135,454 $1.12 Million
Q4 2020

Feb 12, 2021

BUY
$5.76 - $11.95 $124,295 - $257,869
21,579 Added 17.64%
143,903 $982,000
Q3 2020

Nov 09, 2020

BUY
$6.17 - $18.82 $132,685 - $404,724
21,505 Added 21.33%
122,324 $1.36 Million
Q2 2020

Aug 10, 2020

BUY
$1.73 - $6.76 $36,162 - $141,304
20,903 Added 26.16%
100,819 $616,000
Q1 2020

May 15, 2020

BUY
$1.57 - $4.76 $8,656 - $26,246
5,514 Added 7.41%
79,916 $147,000
Q4 2019

Feb 14, 2020

SELL
$1.45 - $4.17 $2,008 - $5,775
-1,385 Reduced 1.83%
74,402 $251,000
Q3 2019

Nov 12, 2019

BUY
$2.05 - $2.69 $6,900 - $9,054
3,366 Added 4.65%
75,787 $164,000
Q2 2019

Aug 14, 2019

SELL
$2.67 - $4.38 $8,802 - $14,440
-3,297 Reduced 4.35%
72,421 $193,000
Q1 2019

May 13, 2019

BUY
$1.86 - $5.94 $11,924 - $38,081
6,411 Added 9.25%
75,718 $360,000
Q4 2018

Feb 14, 2019

SELL
$2.01 - $4.24 $3,127 - $6,597
-1,556 Reduced 2.2%
69,307 $166,000
Q3 2018

Nov 14, 2018

BUY
$4.22 - $7.5 $32,696 - $58,110
7,748 Added 12.28%
70,863 $312,000
Q2 2018

Aug 14, 2018

BUY
$4.75 - $8.0 $299,796 - $504,920
63,115 New
63,115 $454,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.